In addition to an average sales representative’s salary of $55,000, their annual bonuses averaged $71,500 in 2001, according to the American Public Health Association.

NEW YORK- Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker ...

In a historic settlement totaling $7.4 billion, the Sackler family has agreed to permanently cease all opioid sales in the United States and relinquish ownership of Purdue Pharma, the maker of the ...

A former senior partner at McKinsey & Company was sentenced on Friday to six months in federal prison for destroying records of the firm’s work to “turbocharge” Purdue Pharma’s OxyContin ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

WASHINGTON — Purdue Pharma has gained support from attorneys general in 55 U.S. states and territories for a $7.4 billion settlement aimed at resolving thousands of lawsuits related to the ...

Fifty-five attorneys general around the country have now signed on to a $7.4 billion settlement with drugmaker Purdue Pharma and its owners, the Sackler family, over the opioid crisis, officials said.

Purdue Pharma and its former owners in the notorious Sackler family will pay $7.4 billion to settle lawsuits with all 50 states, four territories and Washington, D.C. The deal was finalized Monday ...

A majority of Purdue Pharma's more than 120,000 creditors have voted to approve the company's bankruptcy plan, The New York Times reported July 27.

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

In a historic settlement totaling $7.4 billion, the Sackler family has agreed to permanently cease all opioid sales in the United States and relinquish ownership of Purdue Pharma, the maker of the ...